Inventia Life Science Pty Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Inventia Life Science Pty Ltd. - overview
Established
2013
Location
-, NSW, Australia
Primary Industry
Biotechnology
About
Founded in 2013 and based in Alexandria, Australia, Inventia Life Science Pty Ltd. operates as a developer of 3D bioprinting technology to revolutionize biomedical research and regenerative medicine that can replicate biological processes, disease physiology, and drug responses. Inventia Life Science Pty Ltd. raised an undisclosed amount of venture funding from new investor Prisma Investments.
In December 2021, Inventia Life Science Pty Ltd. raised AUD 35 million in series B funding led by new investor Blackbird, with participation from returning investor Skip Capital. As of 2021, the company is led by CEO Julio Ribeiro. Inventia Life Science Pty Ltd.
provides 3D advanced cell models for neurodegenerative disease drug discovery. The company will use the funding to support the promotion of its RASTRUM 3D cell culture platform, hire new staff, and expand its footprint across the U. S.
Current Investors
Blackbird, Skip Capital, Prisma Investments
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Diagnostic Equipment, Pharmaceutical Research & Development
Website
www.inventia.life
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.